pc:odyss

Odyssey Therapeutics

https://www.odysseytx.com/

Odyssey Therapeutics is a biotechnology company focused on the discovery and development of novel therapeutic candidates to address serious diseases. The company integrates translational science, target validation, and drug development capabilities to advance programs from preclinical stages toward clinical development.

Leadership & Board

Current Number of Employees116

Current LinkedIn Followers13,908

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$213M

Total Amount Raised$213M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$213M

Latest Funding Amount$213M

Latest Funding RoundSeries D

Latest Funding RoundSeries D

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Oct 10, 2025

Series D

$213.00M

―

Related News and Analysis

OpenEvidence Strikes Multi-Year Deal to Embed AUA Guidelines in Its AI Clinical Platform

OpenEvidence Strikes Multi-Year Deal to Embed AUA Guidelines in Its AI Clinical Platform

New updates have been reported about OpenEvidence. OpenEvidence has signed a multi-year collaboration with the American Urological Association...

55m ago

KROMATID Unveils Genomic Integrity Benchmarks as Cornerstone of New Intelligence Platform

KROMATID Unveils Genomic Integrity Benchmarks as Cornerstone of New Intelligence Platform

New updates have been reported about KROMATID. KROMATID will present a new chromosome-scale benchmarking method for detecting genomic...

1h ago

Arkestro Gains Hackett Group Validation and Top Tech Status in Procurement Benchmark

Arkestro Gains Hackett Group Validation and Top Tech Status in Procurement Benchmark

New updates have been reported about Arkestro. Arkestro has been validated in The Hackett Group’s Spring 2026 SolutionMap,...

1h ago

JuliaHub Secures $65 Million to Scale Dyad 3.0, Its Agentic AI Platform for Industrial Digital Twins

JuliaHub Secures $65 Million to Scale Dyad 3.0, Its Agentic AI Platform for Industrial Digital Twins

New updates have been reported about JuliaHub. JuliaHub has raised $65 million in Series B funding and launched...

2h ago

Illuminant Surgical Raises $8.4 Million to Launch Projection-Based Surgical Guidance Platform

Illuminant Surgical Raises $8.4 Million to Launch Projection-Based Surgical Guidance Platform

New updates have been reported about Illuminant Surgical. Illuminant Surgical has secured $8.4 million in seed financing to...

2h ago

Liftoff Adds Ex–J.D. Power CEO and Former Apple Controller to Board for Next Growth Phase

Liftoff Adds Ex–J.D. Power CEO and Former Apple Controller to Board for Next Growth Phase

New updates have been reported about Liftoff. Liftoff has strengthened its governance and scaling capabilities by appointing former...

2h ago

Harness Deepens AI DevOps Push With Launch of Cursor Integration Plugin

Harness Deepens AI DevOps Push With Launch of Cursor Integration Plugin

New updates have been reported about Harness. Harness has introduced a native Cursor plugin that embeds its AI-powered...

2h ago

Back Market Gains Strategic Visibility With Inclusion in TIME100 Most Influential Companies

Back Market Gains Strategic Visibility With Inclusion in TIME100 Most Influential Companies

New updates have been reported about Back Market. Back Market has been named to TIME’s 2026 TIME100 Most...

3h ago

Polymarket Data Shows $25.7 Billion Monthly Volume as Prediction Markets Shift to Continuous Use

Polymarket Data Shows $25.7 Billion Monthly Volume as Prediction Markets Shift to Continuous Use

New updates have been reported about Polymarket. Polymarket sits at the center of a new research report on...

3h ago

Forge Nano Expands Asian Footprint as ALD Breakthrough Aligns With SPAC-Backed IPO Plan

Forge Nano Expands Asian Footprint as ALD Breakthrough Aligns With SPAC-Backed IPO Plan

New updates have been reported about Forge Nano. Forge Nano, Inc., a U.S. semiconductor equipment and advanced materials...

3h ago